Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 29 years old
- You can be a man or a woman
- A healthcare provider has diagnosed you with Irritable Bowel Syndrome (IBS), and you will need to bring proof of this diagnosis to your first appointment
- You currently experience IBS-related pain that is at least a 3 out of 10 in severity, on at least 4 days per week, and this has been going on for the past 3 months
- You have daily access to a computer with an internet connection
- You are able to read and speak English
Who may not be able to join:
- You have another long-term (chronic) pain condition in addition to IBS
- You have been diagnosed with celiac disease or inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
- You have diabetes
- You have had a serious mental health condition that required a hospital stay in the past 6 months
- You are currently pregnant or breastfeeding
- You regularly use opioid painkillers or illegal substances
- You have used probiotics or antibiotics within the 2 weeks before joining the study
- You have a heart or cardiovascular condition, a recent ear injury, metal implants in your head or neck area, or any other condition that would make a specific type of ear stimulation treatment unsafe for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaomei S Cong, Yale University
Phone: 8606179849
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of implementing taVNS - Retention rates; Adherence of implementing taVNS - Duration of usage; Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability); Satisfaction in implementing taVNS; Change in pain intensity assessed using the Brief Pain Inventory (BPI); Changes in IBS symptoms using IBS Symptom Severity Scale (IBS-SSS); Changes in IBS-related Psychophysiological Symptoms - Anxiety using Patient-Reported Outcomes Measurement Information System (PROMIS®) Anxiety 4a; Changes in IBS-related Psychophysiological Symptoms - Fatigue using Patient-Reported Outcomes Mea...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.